AbbVie Ventures
Profile and portfolio
AbbVie Ventures is the corporate venture arm of AbbVie, a pharmaceutical and biotech company. It was founded in 2009 and is based in Cambridge, United States. It invests from seed to Series A. Sectors it names: biotech and life sciences, medical devices.
- Companies backedS1
- 30+
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Seed to Series A |
| Sectors | Biotech and life sciences, Medical devices |
| Geography | North America, Europe, Asia |
| Offices | Cambridge, United States, San Francisco, United States, Oxford, United Kingdom, Ludwigshafen, Germany, Shanghai, China |
Sources: S1 AbbVie Ventures.
Where it invests and who leads it
Geography
- Headquarters
- Cambridge, United States
- Offices
- Cambridge, United States
- San Francisco, United States
- Oxford, United Kingdom
- Ludwigshafen, Germany
- Shanghai, China
Investment regionsS1
LeadersS1
- Christian SchubertVice President, Global Head of AbbVie VenturesLinkedInFirm page
- Donmienne LeungDirector II, Head of AbbVie Ventures EuropeLinkedInFirm page
- Tom WuHead of AbbVie Ventures Asia PacificLinkedInFirm page
- Doug FaunceExecutive DirectorLinkedInFirm page
- Christina VorvisDirectorLinkedInFirm page
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | AbbVie | Single source | S1 |
| Parent industry | Pharmaceuticals and biotech | Single source | S1 |
| Founded | 2009 | Single source | S1 |
| Headquarters | Cambridge, United States | Single source | S1 |
| Status | Active | Single source | S1 |
| Capital source | Parent company only | Single source | S1 |
| Companies backed | 30+ | Single source | S1 |
| Stages | Seed, Series A | Single source | S1 |
Portfolio
The firm's portfolio page lists 16 companies.S2
The firm also states 30+ companies backed. The page list and the stated total measure different things.S1
Every company on the AbbVie Ventures list
16 companies, as listed on the firm's own website.S2 Read the firm's list.
- Accent Therapeutics
- Aleris Therapeutics
- Aquinnah
- Artois
- Caraway Therapeutics
- Caribou Biosciences
- Carisma Therapeutics
- FFECTOR Therapeutics
- Jnana Therapeutics
- Kala Pharmaceuticals
- Morphic Therapeutics
- Palleon Pharmaceuticals
- Quanta Therapeutics
- ReAx
- Rodeo Therapeutics
- Tizona Therapeutics
Official pages
Read the firm's own pages for current information.
Sources
- S1AbbVie VenturesFirm
- S2AbbVie Ventures PortfolioFirm
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by AbbVie Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.